531324 — Roselabs Finance Income Statement
0.000.00%
- IN₹325.00m
- IN₹369.97m
- IN₹11.78m
Annual income statement for Roselabs Finance, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2010 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 0.032 | 1.64 | 0 | 1.51 | 11.8 |
Cost of Revenue | |||||
Gross Profit | 0 | — | — | — | 0.525 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.08 | 29.1 | 4.38 | -19.1 | 13.1 |
Operating Profit | -4.05 | -27.5 | -4.38 | 20.6 | -1.32 |
Net Income Before Taxes | -4.05 | -27.5 | -4.38 | 20.6 | -1.32 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.05 | -25.7 | -4.37 | 20.2 | -1.32 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.05 | -25.7 | -4.37 | 20.2 | -1.32 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -4.05 | -25.7 | -4.37 | 20.2 | -1.32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.405 | -0.783 | -0.437 | 0.323 | -0.13 |
Dividends per Share |